References
- Joint Professional Advisory Committee. Guidelines for the blood transfusion services in the UK. Available: https://www.transfusionguidelines.org/red-book.Accessed 30 March 2021
- American Association of Blood Banks. Standards for blood banks and transfusion services. 31. ed. Gammon R. 2020;Bethesda MD:AABB.
- EQDM. Guide to the preparation, use and quality assurance of blood components. 20. ed. Keitel S, 2020;Strasbourg:Council of Europe.
- Johnson L, Winter KM, Kwok M, Reid S, Marks DC. Evaluation of the quality of blood components prepared using the Reveos automated blood processing system. Vox Sang 2013 1053:225–235. doi:https://doi.org/10.1111/vox.12051
- Plaza EM, Cespedes P, Fernandez H, Sánchez-Guiu MI, Egea JM, Vicente V, Lozano ML, Rivera J. Quality assessment of buffy-coat-derived leucodepleted platelet concentrates in PAS-plasma, prepared by the OrbiSac or TACSI automated system. Vox Sang 2014 1061:38–44. doi:https://doi.org/10.1111/vox.12072
- Stroncek DF, Rebulla P. Platelet transfusions. Lancet 2007;370(9585):427–438.
- van der Meer PF, de Korte D. The effect of holding times of whole blood and its components during processing on in vitro and in vivo quality. Transfus Med Rev 2015;291:24–34. doi:https://doi.org/10.1016/j.tmrv.2014.10.001
- van der Meer PF, de Korte D. Platelet preservation: agitation and containers. Transfus Apher Sci 2011;443:297–304. doi:https://doi.org/10.1016/j.transci.2011.03.005
- Satake M, Kozakai M, Matsumoto M, Matsubayashi K, Taira R, Goto N. Platelet safety strategies in Japan: impact of short shelf life on the incidence of septic reactions. Transfusion 2020 60(4):731–738. doi:https://doi.org/10.1111/trf.15733
- Vollmer T, Dabisch-Ruthe M, Weinstock M, Knabbe C, Dreier J. Late sampling for automated culture to extend the platelet shelf life to 5 days in Germany. Transfusion 2018 587:1654–1664. doi:https://doi.org/10.1111/trf.14617
- Estcourt LJ. Why has demand for platelet components increased? A review. Transfus Med 2014;245:260–268. doi:https://doi.org/10.1111/tme.12155
- Passweg JR, Baldomero H, Bader P, Bonini C, Duarte RF, Dufour C, Gennery A, Kröger N, Kuball J, Lanza F, et al. Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report. Bone Marrow Transplant 2017 526:811–817. doi:https://doi.org/10.1038/bmt.2017.34
- Yuan S, Yang D, Nakamura R, Zhuang L, Al Malki MM, Karanes C, Wang S. Red blood cell and platelet transfusion support in the first 30 and 100 days after allogeneic hematopoietic cell transplant. Transfusion 2020 60(10):2225–2242. doi:https://doi.org/10.1111/trf.15961
- Yazer MH, Shaz B, Seheult JN, Apelseth TO, Korte D, Devin G, Devine D, Doncaster C, Field S, Flanagan P, et al. Trends in platelet distributions from 2008 to 2017: a survey of twelve national and regional blood collectors. Vox Sang 2020 1158:703–711. doi:https://doi.org/10.1111/vox.12917
- Estcourt LJ, Birchall J, Allard S, Bassey SJ, Hersey P, Kerr JP, Mumford AD, Stanworth SJ, Tinegate H. Guidelines for the use of platelet transfusions. Br J Haematol 2017 1763:365–394. doi:https://doi.org/10.1111/bjh.14423
- Stanworth SJ, Navarrete C, Estcourt L. Platelet refractoriness–practical approaches and ongoing dilemmas in patient management. Br J Haematol 2015 1713:297–305. doi:https://doi.org/10.1111/bjh.13597
- Yates N, Stanger S, Wilding R, Cotton S. Approaches to assessing and minimizing blood wastage in the hospital and blood supply chain. ISBT Science Series 2017;121:91–98. doi:https://doi.org/10.1111/voxs.12330
- Flint AW, McQuilten ZK, Irwin G, Rushford K, Haysom HE, Wood EM. Is platelet expiring out of date? A systematic review. Transfus Med Rev 2020 341:42–50. doi:https://doi.org/10.1016/j.tmrv.2019.08.006
- Slichter SJ, Kaufman RM, Assmann SF, McCullough J, Triulzi DJ, Strauss RG, Gernsheimer TB, Ness PM, Brecher ME, Josephson CD, et al. Dose of prophylactic platelet transfusions and prevention of hemorrhage. N Engl J Med 2010 3627:600–613. doi:https://doi.org/10.1056/NEJMoa0904084
- Uhl L, Assmann SF, Hamza TH, Harrison RW, Gernsheimer T, Slichter SJ. Laboratory predictors of bleeding and the effect of platelet and RBC transfusions on bleeding outcomes in the PLADO trial. Blood 2017 130(10):1247–1258. doi:https://doi.org/10.1182/blood-2017-01-757930
- Hanson SR, Slichter SJ. Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement. Blood 1985;665:1105–1109. doi:https://doi.org/10.1182/blood.V66.5.1105.1105
- Stanworth SJ, Estcourt LJ, Powter G, Kahan BC, Dyer C, Choo L, Bakrania L, Llewelyn C, Littlewood T, Soutar R, et al. A no-prophylaxis platelet-transfusion strategy for hematologic cancers. N Engl J Med 2013 36819:1771–1780. doi:https://doi.org/10.1056/NEJMoa1212772
- Wandt H, Schaefer-Eckart K, Wendelin K, Pilz B, Wilhelm M, Thalheimer M, Mahlknecht U, Ho A, Schaich M, Kramer M, et al. Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study. Lancet 2012 380(9850):1309–1316. doi:https://doi.org/10.1016/S0140-6736(12)60689-8
- Stanworth SJ, Hudson CL, Estcourt LJ, Johnson RJ, Wood EM, TOPPS investigators. Risk of bleeding and use of platelet transfusions in patients with hematologic malignancies: recurrent event analysis. Haematologica 2015 100(6):740–747. doi:https://doi.org/10.3324/haematol.2014.118075
- Cornelissen LL, Caram-Deelder C, van der Bom JG, Middelburg RA, Zwaginga JJ. Risk factors for bleeding in haemato-oncology patients-a nested case-control study: the BITE study protocol (Bleeding in thrombocytopenia explained). BMJ Open 2020 10(6):e034710. doi:https://doi.org/10.1136/bmjopen-2019-034710
- Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ. Alternatives to allogeneic platelet transfusion. Br J Haematol 2016 1753:381–392. doi:https://doi.org/10.1111/bjh.14338
- Zhou Z, Feng T, Xie Y, Huang P, Xie H, Tian R, Qian B, Wang R. The effect of recombinant human thrombopoietin (rhTPO) on sepsis patients with acute severe thrombocytopenia: a study protocol for a multicentre randomised controlled trial (RESCUE trial). BMC Infect Dis 2019 191:780. doi:https://doi.org/10.1186/s12879-019-4388-2
- Estcourt LJ, McQuilten Z, Powter G, Dyer C, Curnow E, Wood EM, Stanworth SJ, TREATT Collaborators . The TREATT trial (TRial to evaluAte Tranexamic acid therapy in Thrombocytopenia): safety and efficacy of tranexamic acid in patients with haematological malignancies with severe thrombocytopenia: study protocol for a double-blind randomised controlled trial. Trials 2019;20(1):592.
- Cardenas JC, Zhang X, Fox EE, Cotton BA, Hess JR, Schreiber MA, Wade CE, Holcomb JB, PROPPR study investigators. Platelet transfusions improve hemostasis and survival in a substudy of the prospective, randomized PROPPR trial. Blood Adv 2018 214:1696–1704. doi:https://doi.org/10.1182/bloodadvances.2018017699
- Baharoglu MI, Cordonnier C, Al-Shahi Salman R, de Gans K, Koopman MM, Brand A, Majoie CB, Beenen LF, Marquering HA, Vermeulen M, et al. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial. Lancet 2016;38710038:2605–2613.
- Curley A, Stanworth SJ, Willoughby K, Fustolo-Gunnink SF, Venkatesh V, Hudson C, Deary A, Hodge R, Hopkins V, Lopez Santamaria B, et al. Randomized trial of platelet-transfusion thresholds in neonates. N Engl J Med 2019 380(3):242–251. doi:https://doi.org/10.1056/NEJMoa1807320
- JPAC. The estimated residual risk that a donation made in the infectious window period is not detected on testing: risks specific for HBV, HCV and HIV in the UK. 2020; Available: https://www.transfusionguidelines.org/document-library/position-statements Accessed 30 March 2021
- Bolton-Maggs PHB. Conference report: international Haemovigilance Seminar and the SHOT Annual Symposium, 10-12 July 2018. Transfus Med 2019;294:247–252. doi:https://doi.org/10.1111/tme.12569
- McDonald C, Allen J, Brailsford S, Roy A, Ball J, Moule R, Vasconcelos M, Morrison R, Pitt T. Bacterial screening of platelet components by National Health Service Blood and Transplant, an effective risk reduction measure. Transfusion 2017 575:1122–1131. doi:https://doi.org/10.1111/trf.14085
- de Korte D, Marcelis JH, Verhoeven AJ, Soeterboek AM. Diversion of first blood volume results in a reduction of bacterial contamination for whole-blood collections. Vox Sang 2002 831:13–16. doi:https://doi.org/10.1046/j.1423-0410.2002.00189.x
- McDonald CP, Roy A, Mahajan P, Smith R, Charlett A, Barbara JAJ. Relative values of the interventions of diversion and improved donor-arm disinfection to reduce the bacterial risk from blood transfusion. Vox Sang 2004 863:178–182. doi:https://doi.org/10.1111/j.0042-9007.2004.00404.x
- Savage WJ, Tobian AA, Savage JH, Hamilton RG, Borge PD, Kaufman RM, Ness PM. Transfusion and component characteristics are not associated with allergic transfusion reactions to apheresis platelets. Transfusion 2015 552:296–300. doi:https://doi.org/10.1111/trf.12852
- Tobian AA, Savage WJ, Tisch DJ, Thoman S, King KE, Ness PM. Prevention of allergic transfusion reactions to platelets and red blood cells through plasma reduction. Transfusion 2011 518:1676–1683. doi:https://doi.org/10.1111/j.1537-2995.2010.03008.x
- Cohn CS, Stubbs J, Schwartz J, Francis R, Goss C, Cushing M, Shaz B, Mair D, Brantigan B, Heaton WA, et al. A comparison of adverse reaction rates for PAS C versus plasma platelet units. Transfusion 2014 548:1927–1934. doi:https://doi.org/10.1111/trf.12597
- Goel R, Tobian AAR, Shaz BH. Noninfectious transfusion-associated adverse events and their mitigation strategies. Blood 2019;13317:1831–1839. doi:https://doi.org/10.1182/blood-2018-10-833988
- Cognasse F, Payrat JM, Corash L, Osselaer JC, Garraud O. Platelet components associated with acute transfusion reactions: the role of platelet-derived soluble CD40 ligand. Blood 2008; 11212:4779–4780. author reply 80-1. doi:https://doi.org/10.1182/blood-2008-05-157578
- Cognasse F, Sut C, Hamzeh-Cognasse H, Garraud O. Platelet-derived HMGB1: critical mediator of SARs related to transfusion. Ann Transl Med 2020 84:140. doi:https://doi.org/10.21037/atm.2019.11.81
- Kaufman RM, Assmann SF, Triulzi DJ, Strauss RG, Ness P, Granger S, Slichter SJ. Transfusion-related adverse events in the Platelet Dose study. Transfusion 2015 551:144–153. doi:https://doi.org/10.1111/trf.12791
- Semple JW, McVey MJ, Kim M, Rebetz J, Kuebler WM, Kapur R. Targeting Transfusion-Related Acute Lung Injury: the Journey From Basic Science to Novel Therapies. Crit Care Med 2018 465:e452–e58. doi:https://doi.org/10.1097/CCM.0000000000002989
- Kaufman RM, Anderson KC. Transfusion-associated graft-versus-host disease. In Holland-Frie Cancer Medicine 6, Eds. Kufe DW, Pollock RE, Weichselbaum RR 2003;BC Decker:Hamilton(ON).Available: https://www.ncbi.nlm.nih.gov/books/NBK12934/Accessed 30 March 2021
- Belizaire R, Makar RS. Non-Alloimmune mechanisms of thrombocytopenia and refractoriness to platelet transfusion. Transfus Med Rev 2020;344:242–249. doi:https://doi.org/10.1016/j.tmrv.2020.09.002
- Hess JR, Trachtenberg FL, Assmann SF, Triulzi DJ, Kaufman RM, Strauss RG, Granger S, Slichter SJ. Clinical and laboratory correlates of platelet alloimmunization and refractoriness in the PLADO trial. Vox Sang 2016 1113:281–291. doi:https://doi.org/10.1111/vox.12411
- Saris A, Pavenski K. Human Leukocyte Antigen Alloimmunization and Alloimmune Platelet Refractoriness. Transfus Med Rev 2020;344:250–257. doi:https://doi.org/10.1016/j.tmrv.2020.09.010
- Pagano MB, Katchatag BL, Khoobyari S, Van Gerwen M, Sen N, Rebecca Haley N, Gernsheimer TB, Hess JR, Metcalf RA. Evaluating safety and cost-effectiveness of platelets stored in additive solution (PAS-F) as a hemolysis risk mitigation strategy. Transfusion 2019 594:1246–1251. doi:https://doi.org/10.1111/trf.15138
- Quillen K, Sheldon SL, Daniel-Johnson JA, Lee-Stroka AH, Flegel WA. A practical strategy to reduce the risk of passive hemolysis by screening plateletpheresis donors for high-titer ABO antibodies. Transfusion 2011 511:92–96. doi:https://doi.org/10.1111/j.1537-2995.2010.02759.x
- Dunbar NM. Does ABO and RhD matching matter for platelet transfusion? Hematology Am Soc Hematol Educ Program 2020;2020(1):512–517. doi:https://doi.org/10.1182/hematology.2020000135
- Vostal JG. Efficacy evaluation of current and future platelet transfusion products (review). J Trauma 2006;60(Suppl 6):S78–82.
- Slichter SJ, Jones M, Ransom J, Gettinger I, Jones MK, Christoffel T, Pellham E, Bailey SL, Corson J, Bolgiano D, et al. Review of in vivo studies of dimethyl sulfoxide cryopreserved platelets. Transfus Med Rev 2014 284:212–225. doi:https://doi.org/10.1016/j.tmrv.2014.09.001
- Kelly K, Cancelas JA, Szczepiorkowski ZM, Dumont DF, Rugg N, Dumont LJ. Frozen platelets-development and future directions. Transfus Med Rev 2020 344:286–293. doi:https://doi.org/10.1016/j.tmrv.2020.09.008
- Mack JP, Miles J, Stolla M. Cold-Stored Platelets: review of Studies in Humans. Transfus Med Rev 2020;344:221–226. doi:https://doi.org/10.1016/j.tmrv.2020.08.003
- Stolla M, Fitzpatrick L, Gettinger I, Bailey SL, Pellham E, Christoffel T, Slichter SJ. In vivo viability of extended 4 degrees C-stored autologous apheresis platelets. Transfusion 2018 5810:2407–2413. doi:https://doi.org/10.1111/trf.14833
- Barroso J, Osborne B, Teramura G, Pellham E, Fitzpatrick M, Biehl R, Yu A, Pehta J, Slichter SJ. Safety evaluation of a lyophilized platelet-derived hemostatic product. Transfusion 2018 5812:2969–2977. doi:https://doi.org/10.1111/trf.14972
- Bynum JA, Meledeo MA, Peltier GC, McIntosh CS, Taylor AS, Montgomery RK, Reddoch–Cardenas KM, Getz TM, Fitzpatrick MG, Cap AP. Evaluation of a lyophilized platelet-derived hemostatic product. Transfusion 2019 59S2:1490–1498. doi:https://doi.org/10.1111/trf.15167
- Kehrel, Brodde MF, Kehrel BE. State of the art in platelet function testing. Transfusion Medicine and Hemotherapy 2013;40:73–86. 2 doi:https://doi.org/10.1159/000350469
- Panzer S, Jilma P. Methods for testing platelet function for transfusion medicine. Vox Sang 2011;1011:1–9.
- Bertolini F, Murphy S. A multicenter inspection of the swirling phenomenon in platelet concentrates prepared in routine practice. Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion. Transfusion 1996;362:128–132. doi:https://doi.org/10.1046/j.1537-2995.1996.36296181924.x
- Dumont LJ, Gulliksson H, van der Meer PF, Murphy S, Nixon JG, de Wildt-Eggen J, VandenBroeke T, AuBuchon JP. Interruption of agitation of platelet concentrates: a multicenter in vitro study by the BEST Collaborative on the effects of shipping platelets. Transfusion 2007 479:1666–1673. doi:https://doi.org/10.1111/j.1537-2995.2007.01339.x
- Dumont LJ, AuBuchon JP, Gulliksson H, Slichter SJ, Elfath MD, Holme S, Murphy JR, Rose LE, Popovsky MA, Murphy S. In vitro pH effects on in vivo recovery and survival of platelets: an analysis by the BEST Collaborative. Transfusion 2006 468:1300–1305. doi:https://doi.org/10.1111/j.1537-2995.2006.00895.x
- Goodrich RP, Li J, Pieters H, Crookes R, Roodt J, Heyns A du P. Correlation of in vitro platelet quality measurements with in vivo platelet viability in human subjects. Vox Sang 2006 90(4):279–285. doi:https://doi.org/10.1111/j.1423-0410.2006.00761.x
- Holme S, Moroff G, Murphy S. A multi-laboratory evaluation of in vitro platelet assays: the tests for extent of shape change and response to hypotonic shock. Biomedical Excellence for Safer Transfusion Working Party of the International Society of Blood Transfusion. Transfusion 1998;381:31–40. doi:https://doi.org/10.1046/j.1537-2995.1998.38198141495.x
- Levin E, Jenkins C, Culibrk B, Gyöngyössy-Issa MIC, Serrano K, Devine DV. Development of a quality monitoring program for platelet components: a report of the first four years’ experience at Canadian Blood Services. Transfusion 2012 524:810–818. doi:https://doi.org/10.1111/j.1537-2995.2011.03402.x
- Getz TM, Montgomery RK, Bynum JA, Aden JK, Pidcoke HF, Cap AP. Storage of platelets at 4 degrees C in platelet additive solutions prevents aggregate formation and preserves platelet functional responses. Transfusion 2016 566:1320–1328. doi:https://doi.org/10.1111/trf.13511
- Johnson L, Coorey CP, Marks DC. The hemostatic activity of cryopreserved platelets is mediated by phosphatidylserine-expressing platelets and platelet microparticles. Transfusion 2014;548:1917–1926. doi:https://doi.org/10.1111/trf.12578
- Ting LH, Feghhi S, Taparia N, Smith AO, Karchin A, Lim E, John AS, Wang X, Rue T, White NJ, et al. Contractile forces in platelet aggregates under microfluidic shear gradients reflect platelet inhibition and bleeding risk. Nat Commun 2019 10(1):1204. doi:https://doi.org/10.1038/s41467-019-09150-9
- Johnson L, Raynel S, Seghatchian J, Marks DC. Platelet microparticles in cryopreserved platelets: potential mediators of haemostasis. Transfus Apher Sci 2015 532:146–152. doi:https://doi.org/10.1016/j.transci.2015.10.011
- Rossaint J, Margraf A, Zarbock A. Role of platelets in leukocyte recruitment and resolution of inflammation. Front Immunol 2018;9:2712. doi:https://doi.org/10.3389/fimmu.2018.02712
- Bikker A, Bouman E, Sebastian S, Korporaal SJA, Urbanus RT, Fijnheer R, Boven LA, Roest M. Functional recovery of stored platelets after transfusion. Transfusion 2016 565:1030–1037. doi:https://doi.org/10.1111/trf.13544
- Owens M, Holme S, Heaton A, Sawyer S, Cardinali S. Post-transfusion recovery of function of 5-day stored platelet concentrates. Br J Haematol 1992 80(4):539–544. doi:https://doi.org/10.1111/j.1365-2141.1992.tb04570.x
- Ho-Tin-Noe B, Boulaftali Y, Camerer E. Platelets and vascular integrity: how platelets prevent bleeding in inflammation. Blood 2018;1313:277–288. doi:https://doi.org/10.1182/blood-2017-06-742676
- Baimukanova G, Miyazawa B, Potter DR, Muench MO, Bruhn R, Gibb SL, Spinella PC, Cap AP, Cohen MJ, Pati S. Platelets regulate vascular endothelial stability: assessing the storage lesion and donor variability of apheresis platelets. Transfusion 2016 56Suppl 1:S65–75. doi:https://doi.org/10.1111/trf.13532
- Johnson L, Reid S, Tan S, Vidovic D, Marks DC. PAS-G supports platelet reconstitution after cryopreservation in the absence of plasma. Transfusion 2013;5310:2268–2277.
- Morrow GB, Whyte CS, Mutch NJ. Functional plasminogen activator inhibitor 1 is retained on the activated platelet membrane following platelet activation. Haematologica 2020;10512:2824–2833. doi:https://doi.org/10.3324/haematol.2019.230367
- Blessinger SA, Tran JQ, Jackman RP, Gilfanova R, Rittenhouse J, Gutierrez AG, Heitman JW, Hazegh K, Kanias T, Muench MO. Immunodeficient mice are better for modeling the transfusion of human blood components than wild-type mice. PLoS One 2020 157:e0237106. doi:https://doi.org/10.1371/journal.pone.0237106
- Gelderman MP, Cheng C, Xu F, Skripchenko A, Ryan J, Li Y, Whitley P, Wagner SJ, Vostal JG. Validation of a SCID mouse model for transfusion by concurrent comparison of circulation kinetics of human platelets, stored under various temperature conditions, between human volunteers and mice. Transfusion 2020 60(10):2379–2388. doi:https://doi.org/10.1111/trf.15953
- De Bruin S, van de Weerdt EK, Sijbrands D, Vlaar R, Gouwerok E, Biemond BJ, Vlaar APJ, van Bruggen R, de Korte D. Biotinylation of platelets for transfusion purposes a novel method to label platelets in a closed system. Transfusion 2019 599:2964–2973. doi:https://doi.org/10.1111/trf.15451
- Aurich K, Wesche J, Palankar R, Schluter R, Bakchoul T, Greinacher A. Magnetic nanoparticle labeling of human platelets from platelet concentrates for recovery and survival studies. ACS Appl Mater Interfaces 2017 940:34666–34673. doi:https://doi.org/10.1021/acsami.7b10113
- Murphy S, Gardner FH. Effect of storage temperature on maintenance of platelet viability–deleterious effect of refrigerated storage. N Engl J Med 1969;280(20):1094–1098. doi:https://doi.org/10.1056/NEJM196905152802004
- D’Alessandro A, Thomas KA, Stefanoni D, Gamboni F, Shea SM, Reisz JA, Spinella PC. Metabolic phenotypes of standard and cold-stored platelets. Transfusion 2020;60(Suppl 3):S96–S106.
- Wagner SJ, Getz TM, Thompson-Montgomery D, Turgeon A. Preliminary characterization of the properties of cold-stored apheresis platelets suspended in PAS-III with and without an 8-hour room temperature hold. Transfusion 2020 60(11):2489–2493. doi:https://doi.org/10.1111/trf.15964
- Strandenes G, Sivertsen J, Bjerkvig CK, Fosse TK, Cap AP, Del Junco DJ, Kristoffersen EK, Haaverstad R, Kvalheim V, Braathen H, et al. A pilot trial of platelets stored cold versus at room temperature for complex cardiothoracic surgery. Anesthesiology 2020 1336:1173–1183. doi:https://doi.org/10.1097/ALN.0000000000003550
- Chilled Platelet CHIPS Study. 2020; Available: https://rdcr.org/thor-investigators-awarded-26-million-dod-cold-stored-platelets-research/. Accessed 30March 2021
- Hegde SN, Akbar H, Nestheide S, Wellendorf AM, Bohan B, Johnson JF, Zheng Y, Cancelas JA. RhoA targetting suppresses cold-induced platelet lesion and allows refrigerated storage of functional human platelets for fourteen days. Blood 2019 134 Suppl 1:99. doi:https://doi.org/10.1182/blood-2019-125359
- Wood B, Johnson L, Hyland RA, Marks DC. Maximising platelet availability by delaying cold storage. Vox Sang 2018 1135:403–411. doi:https://doi.org/10.1111/vox.12649
- Six KR, Devloo R, Compernolle V, Feys HB. Impact of cold storage on platelets treated with Intercept pathogen inactivation. Transfusion 2019 598:2662–2671. doi:https://doi.org/10.1111/trf.15398
- Hervig TA, Doughty HA, Cardigan RA, Apelseth TO, Hess JR, Noorman F, Bohoněk M, Yazer MH, Lu J, Wendel S, et al. Re-introducing whole blood for transfusion: considerations for blood providers. Vox Sang 2021 1162:167–174. doi:https://doi.org/10.1111/vox.12998
- Slichter SJ, Fitzpatrick L, Osborne B, Christoffel T, Gettinger I, Pellham E, Bailey SL, Jones MK, Herzig MC, Cap AP. Platelets stored in whole blood at 4 degrees C: in vivo posttransfusion platelet recoveries and survivals and in vitro hemostatic function. Transfusion 2019 596:2084–2092. doi:https://doi.org/10.1111/trf.15302
- Valeri CR, Ragno G, Khuri S. Freezing human platelets with 6 percent dimethyl sulfoxide with removal of the supernatant solution before freezing and storage at −80 degrees C without postthaw processing. Transfusion 2005;4512:1890–1898. doi:https://doi.org/10.1111/j.1537-2995.2005.00647.x
- Waters L, Padula MP, Marks DC, Johnson L. Calcium chelation: a novel approach to reduce cryopreservation-induced damage to frozen platelets. Transfusion 2020 60(7):1552–1563. doi:https://doi.org/10.1111/trf.15799
- Six KR, Delabie W, Devreese KMJ, Johnson L, Marks DC, Dumont LJ, Compernolle V, Feys HB. Comparison between manufacturing sites shows differential adhesion, activation, and GPIbalpha expression of cryopreserved platelets. Transfusion 2018 5811:2645–2656. doi:https://doi.org/10.1111/trf.14828
- Johnson L, Waters L, Green S, Wood B, Marks DC. Freezing expired platelets does not compromise in vitro quality: an opportunity to maximize inventory potential. Transfusion 2020 60(3):454–459. doi:https://doi.org/10.1111/trf.15616
- Slichter SJ, Dumont LJ, Cancelas JA, Jones M, Gernsheimer TB, Szczepiorkowski ZM, Dunbar NM, Prakash G, Medlin S, Rugg N, et al. Safety and efficacy of cryopreserved platelets in bleeding patients with thrombocytopenia. Transfusion 2018 589:2129–2138. doi:https://doi.org/10.1111/trf.14780
- Reade MC, Marks DC, Bellomo R, Deans R, Faulke DJ, Fraser JF, Gattas DJ, Holley AD, Irving DO, Johnson L, et al. A randomized, controlled pilot clinical trial of cryopreserved platelets for perioperative surgical bleeding: the CLIP-I trial (Editorial, p. 2759). Transfusion 2019 599:2794–2804. doi:https://doi.org/10.1111/trf.15423
- Fitzpatrick GM, Cliff R, Tandon N. Thrombosomes: a platelet-derived hemostatic agent for control of noncompressible hemorrhage. Transfusion 2013;53Suppl 1:100S–06S. doi:https://doi.org/10.1111/trf.12043
- NCT04631211. Thrombosomes in bleeding thrombocytopenic patients study. Available: https://clinicaltrials.gov/ct2/show/NCT04631211. Accessed 10 August 2021
- van der Meer PF, de Korte D. Platelet additive solutions: A review of the latest developments and their clinical implications. Transfus Med Hemother 2018;452:98–102. doi:https://doi.org/10.1159/000487513
- Germain M, Gregoire Y, Vassallo RR, Acker JP, Cardigan R, de Korte D, Irving DO, Bégué S. Quality control of apheresis platelets: a multicentre study to evaluate factors that can influence pH measurement. Vox Sang 2017 1124:318–325. doi:https://doi.org/10.1111/vox.12505
- Hill BG, Shiva S, Ballinger S, Zhang J, Darley-Usmar VM. Bioenergetics and translational metabolism: Implications for genetics, physiology and precision medicine. Biol Chem 2019 4011:3–29. doi:https://doi.org/10.1515/hsz-2019-0268
- Bontekoe IJ, van der Meer PF, van den Hurk K, Verhoeven AJ, de Korte D. Platelet storage performance is consistent by donor: A pilot study comparing “good” and “poor” storing platelets. Transfusion 2017 5710:2373–2380. doi:https://doi.org/10.1111/trf.14238
- Stefely JA, Gailey M, Knudson M, Dumont LJ, Raife TJ, Samia NI. Retrospective cohort studies of repeat donors reveal donor-dependent variability in the recovery of transfused platelets. Transfusion 2020 60(8):1837–1845. doi:https://doi.org/10.1111/trf.15865
- Garner SF, Furnell A, Kahan BC, Jones CI, Attwood A, Harrison P, Kelly AM, Goodall AH, Cardigan R, Ouwehand WH. Platelet responses to agonists in a cohort of highly characterised platelet donors are consistent over time. Vox Sang 2017 1121:18–24. doi:https://doi.org/10.1111/vox.12468
- Kelly AM, Garner SF, Foukaneli T, Godec TR, Herbert N, Kahan BC, Deary A, Bakrania L, Llewelyn C, Ouwehand WH, et al. The effect of variation in donor platelet function on transfusion outcome: A semirandomized controlled trial. Blood 2017 130(2):214–220. doi:https://doi.org/10.1182/blood-2017-01-759258